Due to the metabolic pathway no clinically significant pharmacokinetic interactions are expected between enfuvirtide and nevirapine.
Metabolismiteest tulenevalt ei ole enfuvirtiidi ja nevirapiini vahel oodata kliiniliselt olulisi farmakokineetilisi koostoimeid.